ARL13B
ARL13B is a protein that in humans is encoded by the ARL13B gene. It is a member of the ADP-ribosylation factor-like (ARL) family of proteins, which are a subgroup of the larger ARF family. ARL13B is involved in cilia formation and function, and mutations in this gene have been associated with Joubert syndrome, a rare genetic disorder.
Function[edit]
ARL13B is a ciliary protein that plays a crucial role in cilia function. Cilia are small, hair-like structures present on the surface of all mammalian cells. They are involved in many physiological processes, including sensory perception, cell movement, and signal transduction. ARL13B is specifically involved in the regulation of ciliary length and structure, and it is required for the proper movement of proteins to the cilia.
Clinical significance[edit]
Mutations in the ARL13B gene have been associated with Joubert syndrome, a rare genetic disorder characterized by brain abnormalities, eye abnormalities, kidney disease, and polydactyly. Joubert syndrome is a ciliopathy, a class of diseases caused by dysfunction of cilia. The symptoms of Joubert syndrome are thought to be caused by the disruption of cilia-dependent signaling pathways.
Research[edit]
Research on ARL13B has provided insights into the function of cilia and the pathogenesis of ciliopathies. Studies have shown that ARL13B is required for the proper localization of other ciliary proteins, and that it interacts with several other proteins to regulate ciliary structure and function. In addition, research on ARL13B has contributed to our understanding of the molecular mechanisms underlying Joubert syndrome and other ciliopathies.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
